Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Fatigue is a major complaint of multiple sclerosis (MS) patients. However, little is known about its pathophysiological mechanisms. Evidence from chronic fatigue syndrome and studies on sickness behaviour suggest that immune and neuroendocrine factors may play a causative role in the development of fatigue. METHODS: We compared whole blood stimulatory capacity for pro- (TNFalpha, IFNgamma) and anti-inflammatory cytokines (IL-10) as well as hypothalamo-pituitary-adrenal (HPA) axis function in 15 MS patients with marked fatigue and 15 patients without fatigue as determined by the Fatigue Severity Scale (FSS). RESULTS: Proinflammatory cytokines were significantly higher (TNFalpha: 478.9 v 228.2 pg/ml, p = 0.01; IFNgamma: 57.6 v 27.8 pg/ml; p = 0.01) in MS patients with fatigue. Furthermore, TNFalpha values significantly correlated with daytime sleepiness as measured by the Epworth Sleepiness Scale (r = 0.64, p = 0.001). Controlling for disease activity (as measured by the Cambridge Multiple Sclerosis Basic Score), disease duration, Expanded Disability Status Scale, and depression further increased the correlation of cytokine production and fatigue. HPA axis activity was not related to fatigue but was modestly correlated with cognitive impairment. CONCLUSION: Our data suggest that fatigue in MS is at least partially mediated through activation of proinflammatory cytokines. In line with earlier findings, HPA axis dysfunction seems not to be relevant in MS fatigue pathogenesis but appears to be linked to cognitive impairment. Our findings suggest that increased levels of inflammatory cytokines may be involved in MS fatigue. Investigation of cytokine profiles may increase the understanding of fatigue pathogenesis in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Quantification of Sleepiness: A New Approach
Hoddes, E., Zarcone, V., Smythe, H., Phillips, R., & Dement, W. C. (1973) · Psychophysiology · doi:10.1111/j.1469-8986.1973.tb00801.x · Cited by 2,538
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Smith, A. (2016) · PsycTESTS Dataset · doi:10.1037/t27513-000 · Cited by 1,277
Cited by
Reciprocal regulation of the neural and innate immune systems
Irwin, M. R., & Cole, S. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3042 · Cited by 910
“and in individuals with inflammatory diseases such as multiple sclerosi”
BackgroundD'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
The Role of Inflammation in Depression and Fatigue
Lee, C.-H., & Giuliani, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01696 · Cited by 640
TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription
Cavadini, G., Petrzilka, S., Kohler, P., Jud, C., Tobler, I., Birchler, T., & Fontana, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701466104 · Cited by 421
Fatigue as a symptom or comorbidity of neurological diseases
Penner, I.-K., & Paul, F. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.117 · Cited by 404
Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment
Braley, T. J., & Chervin, R. D. (2010) · Sleep · doi:10.1093/sleep/33.8.1061 · Cited by 403
Origin of Fatigue in Multiple Sclerosis: Review of the Literature
Kos, D., Kerckhofs, E., Nagels, G., D'hooghe, M. B., & Ilsbroukx, S. (2008) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968306298934 · Cited by 397
Fatigue in Healthy and Diseased Individuals
Finsterer, J., & Mahjoub, S. Z. (2014) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909113494748 · Cited by 363
The neuroimmune basis of fatigue
Dantzer, R., Heijnen, C. J., Kavelaars, A., Laye, S., & Capuron, L. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.10.003 · Cited by 346
Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis
Manjaly, Z.-M., Harrison, N. A., Critchley, H. D., Do, C. T., Stefanics, G., Wenderoth, N., Lutterotti, A., Müller, A., & Stephan, K. E. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320050 · Cited by 321
Taylor, A. G., Goehler, L. E., Galper, D. I., Innes, K. E., & Bourguignon, C. (2010) · EXPLORE · doi:10.1016/j.explore.2009.10.004 · Cited by 287
Sarcoidosis-associated fatigue
Drent, M., Lower, E. E., & De Vries, J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00002512 · Cited by 285
Lindqvist, D., Hall, S., Surova, Y., Nielsen, H. M., Janelidze, S., Brundin, L., & Hansson, O. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.007 · Cited by 276
Cancer‐related fatigue: Implications for breast cancer survivors
Berger, A. M., Gerber, L. H., & Mayer, D. K. (2012) · Cancer · doi:10.1002/cncr.27475 · Cited by 264
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
“Given the strong positive relationship between TNF-α levels and degree of physical disability, it is of theoretical relevance that the levels of TNF-α and other PICs correlate significantly with the severity of fatigue which affects the vast majority of people with this illness [6,54-56].”
BackgroundHadjimichael, O., Vollmer, T., & Oleen-Burkey, M. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-100 · Cited by 240
“Additional factors may be physiological: it has been reported that an increase in proinflammatory cytokines may be a possible contributor to primary fatigue in MS [40,42].”
Patejdl, R., Penner, I. K., Noack, T. K., & Zettl, U. K. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.11.005 · Cited by 141
A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome
Morris, G., & Maes, M. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-012-9324-8 · Cited by 117
Hanken, K., Eling, P., & Hildebrandt, H. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00264 · Cited by 92
“(14) compared whole blood stimulatory capacity for pro- (TNF-α, IFN-γ) and antiinflammatory (IL-10) cytokines in 15 MS patients with and 15 MS patients without fatigue as determined by the FSS.”
BackgroundMethodFatigue symptoms relate to systemic inflammation in patients with type 2 diabetes
Lasselin, J., Layé, S., Dexpert, S., Aubert, A., Gonzalez, C., Gin, H., & Capuron, L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.03.003 · Cited by 77
Veauthier, C., Hasselmann, H., Gold, S. M., & Paul, F. (2016) · EPMA Journal · doi:10.1186/s13167-016-0073-3 · Cited by 71
Prevalence of fatigue in patients with multiple sclerosis and its effect on the quality of life
Nagaraj, K., Taly, A. B., Gupta, A., Prasad, C., & Christopher, R. (2013) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.118774 · Cited by 64
“Journal of Neurosciences in Rural Practice | July - September 2013 | Vol 4 | Issue 3 281 interferon‐γ levels are found in fatigued MS patients compared to non‐fatigued patients and considered to be responsible for fatigue.[31]”
BackgroundFatigue, depression and progression in multiple sclerosis
Koch, M., Uyttenboogaart, M., van Harten, A., Heerings, M., & De Keyser, J. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508088937 · Cited by 59
Bol, Y., Duits, A. A., Vertommen-Mertens, C. E. R., Hupperts, R. M. M., Romberg-Camps, M. J. L., Verhey, F. R. J., & Vlaeyen, J. W. S. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.11.011 · Cited by 28
“However, attempts to correlate MS-related fatigue with immune system activation, assessed by circulating levels of cytokines, have so far led to inconsistent results [46,47].”
Result
Metadata
- Authors
- Heesen, C.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2006-01-01
- Volume
- 77
- Issue
- 1
- Pages
- 34-39
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2153084624
- Cited by
- 345
- References
- 33
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.